• James Glover, senior vice president and CFO of Beckman Coulter (Fullerton, California), will retire from the company effective June 30 after 23 years of service. Beckman Coulter is a manufacturer of biomedical testing instrument systems, tests and supplies that simplify and automate laboratory processes.

• Dr. Thomas Williams has been named chief science officer and vice president, research and development of Exagen Diagnostics (Albuquerque, New Mexico). Prior to joining Exagen on a full-time basis, Williams served as the company's special advisor for molecular pathology. Additionally, he was vice chairman, department of pathology, at the University of New Mexico (UNM) School of Medicine and director of the Genetics and Cytometry Division at TriCore Reference Laboratories. Williams will continue with UNM as part-time professor of pathology. Exagen Diagnostics develops genomic marker-based in vitro diagnostic kits for disease prognosis and prediction of treatment response.

• Patrick Jackle has joined Pacific Biometrics (Seattle) as business development manager. Jackle brings to PBI more than 15 years of healthcare sales experience, most recently as district manager of Novartis Pharmaceuticals. Pacific Biometrics is a provider of specialized central laboratory and contract research services. The company also owns several technologies, including monitoring devices for glucose and changes in bone turnover, an advanced isothermal DNA amplification technology, and a gene-based cell-viability technology to distinguish live from dead cells in a broad range of diagnostic applications.

• Cornel Schoelgens has been named managing director-Europe for Zonare Medical Systems (Mountain View, California), the company reported this week at the European Congress of Radiology meeting in Vienna, Austria. Schoelgens joins Zonare with more than 20 years of experience in the area of diagnostic imaging, most recently as managing director for SonoSite in Germany. Zonare Medical Systems is a developer of ultrasound technology.